Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumoursIgnacio Melero, Thomas F. Gajewski, Martin Schüler et al.|Nature|2024Cited by 107
728 A phase 1/2 study of JK08, an IL-15 antibody fusion protein targeting CTLA-4, in patients with advanced solid tumorsNuria Kotecki, Naimish Pandya, Sylvie Rottey et al.|Regular and Young Investigator Award Abstracts|2023Cited by 1
A phase 1/2 study of JK06, a 5T4 antibody drug conjugate, in patients with unresectable locally advanced or metastatic cancer.Nuria Kotecki, Naimish Pandya, Sylvie Rottey et al.|Journal of Clinical Oncology|2025Cited by 0
Abstract CT250: A phase 1b / 2 study of JK06, a 5T4-targeted antibody drug conjugate, in patients with unresectable locally advanced or metastatic cancerOmar Saavedra, Nuria Kotecki, Fabricio Racca et al.|Cancer Research|2026Cited by 0